Methadone Half-Life: 15-120 Hours with Average of 24 Hours
Methadone has a highly variable elimination half-life ranging from 15 to 120 hours, with an average of approximately 24 hours 1. This marked interindividual variability is one of methadone's most clinically significant characteristics and directly impacts dosing strategies.
Key Pharmacokinetic Properties
The FDA drug label specifies that methadone's plasma elimination half-life typically ranges from 8 to 59 hours 2, though clinical guidelines cite the broader range of 15-120 hours 1. For the active (R)-enantiomer specifically, mean values around 40 hours have been documented 3.
Critical Clinical Implications
The discrepancy between methadone's analgesic duration (4-8 hours) and its elimination half-life creates significant risk for drug accumulation 2. This mismatch means:
- Steady-state plasma concentrations are not reached until 3-5 days of dosing 2
- In some individuals, steady state may take several days to 2 weeks 1
- Peak respiratory depressant effects occur later and persist longer than peak analgesic effects 2
- The drug accumulates with repeated dosing, requiring dosing intervals no more frequent than every 8 hours 4
Factors Affecting Half-Life Variability
Drug Interactions
CYP450 enzyme inducers and inhibitors significantly alter methadone half-life 5:
- Inducers (rifampin, phenobarbital, phenytoin, carbamazepine, nevirapine, efavirenz) decrease methadone concentrations and shorten half-life, potentially causing withdrawal 3
- Inhibitors (fluconazole, paroxetine) increase methadone concentrations and prolong half-life 3
Pregnancy
Pregnancy substantially shortens methadone half-life due to CYP450 enzyme induction and increased volume of distribution 2. One case report documented a half-life as short as 9.22 hours in a postpartum patient requiring 900 mg daily 6.
Hepatic Function
Methadone is metabolized primarily by hepatic pathways (CYP3A4, CYP2B6, CYP2C19), so patients with liver impairment risk drug accumulation despite the same dosing interval 2.
Clinical Monitoring Requirements
Because of the long and variable half-life, observe for drug accumulation and adverse effects especially over the first 4-5 days 1. The NCCN guidelines emphasize that methadone should not be titrated more frequently than every 5-7 days 1.
Warning Signs
Any significant sedation or marked pain improvement before day 5 indicates the dose may be too high, placing the patient at risk for oversedation or respiratory depression by days 5-7 if not immediately adjusted 1.
Dosing Implications
The long half-life necessitates:
- Initial dosing should not exceed 30-40 mg on day 1 2
- Methadone is typically dosed every 8-12 hours for chronic pain 1
- Some patients with rapid metabolism may require three times daily dosing to maintain therapeutic levels 6
- Deaths have occurred in early treatment due to cumulative effects from the first several days' dosing 2
Common Pitfall
The most dangerous error is failing to account for methadone's delayed accumulation. Providers may be tempted to increase doses too quickly when patients report inadequate analgesia in the first 3-4 days, not recognizing that steady state has not yet been achieved. Wait at least 5-7 days between dose adjustments 1.